Showing results (1601-1610 of 1,768) with videos related to
Sort By:
Pageof 177
Iscience|August 19, 2022
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptineDespoina Aslanoglou, Suzanne Bertera, Laura Friggeri, et al.Molecular Therapy. Oncology|April 6, 2026
Identification of small molecules that enhance aminoglycoside-mediated suppression of <i>CFTR</i> and <i>NF1</i> nonsense mutationsJoshua Sammons, Jianguo Chen, Kari Thrasher, et al.Breast Cancer Research : BCR|November 27, 2015
β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasionSarah J Creed, Caroline P Le, Mona Hassan, et al.Molecular Human Reproduction|December 17, 2009
Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosisJan J Brosens, Andrea Hodgetts, Fahkera Feroze-Zaidi, et al.Journal of Electrocardiology|May 19, 2009
Overcoming barriers to developing seamless ST-segment elevation myocardial infarction care systems in the United States: recommendations from a comprehensive Prehospital 12-lead Electrocardiogram Working GroupDaniel M Frendl, Sebastian T Palmeri, J Robert Clapp, et al.Plos One|June 29, 2016
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 StudyDavid N Franz, Elena Belousova, Steven Sparagana, et al.Aquatic Toxicology (Amsterdam, Netherlands)|July 15, 2018
Transcriptomics investigation of thyroid hormone disruption in the olfactory system of the Rana [Lithobates] catesbeiana tadpoleKevin W Jackman, Nik Veldhoen, Rachel C Miliano, et al.Nature|October 15, 2013
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugsRon O Dror, Hillary F Green, Celine Valant, et al.JCO Oncology Practice|January 6, 2021
Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research StatementDax Kurbegov, Patricia Hurley, David M Waterhouse, et al.Antimicrobial Agents and Chemotherapy|July 23, 2008
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapyKayode K Ojo, J Robert Gillespie, Aaron J Riechers, et al.Pageof 177